SLV Stock UPDATES Silver Trust Ishares (SLV) 18.42 09/07/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Silver Trust Ishares (SLV) 18.42 $SLV

Watch for iShares Silver Trust to Potentially Rebound After Falling 1.60% Yesterday
Comtex SmarTrend(R) - Tue Sep 02, 5:21PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $18.32 to a high of $18.51. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $18.55 on volume of 9.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 1.60%, iShares Silver Trust Offers Investors Better Value
Comtex SmarTrend(R) - Tue Sep 02, 5:20PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $18.32 to a high of $18.51. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $18.55 on volume of 9.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Take a Chance on S&P 500, Since Weak Volume Can Still Work
at The Street - Tue Sep 02, 3:30PM CDT
September isn’t usually the best month of the year, but neither is August -- and August was fantastic.

'Fast Money' Recap: Look for the Underperforming Stocks
at The Street - Wed Aug 27, 4:00AM CDT
The trading panel discussed the S&P 500's historic close, Microsoft and Warren Buffett's Burger King involvement.

Economic Recovery Doesn't Satisfy Fed as Stocks Soar Higher
at The Street - Thu Aug 21, 10:14AM CDT
Low inflation and slack in the labor market has kept policymakers dovish, leading to strength in U.S. equities and in high-beta sectors.

KOP, SLV, GDX, MANT, NRP, WYN Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Mon Aug 18, 7:26AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Koppers Holdings Inc (NYSE:KOP), Stealth Ventures Ltd (NYSE:SLV), Goldex Resources Corp (NYSE:GDX), MANTECH INTERNATIONAL CORPORATION (NASDAQ:MANT), Natural Resource Partners LP (NYSE:NRP), Wyndham Worldwide Corp (NYSE:WYN) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

iShares Silver Trust Set to Possibly Rebound After Yesterday's Selloff of 1.26%
Comtex SmarTrend(R) - Fri Aug 15, 3:58PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $18.74 to a high of $18.98. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $18.91 on volume of 11.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Valuation of Assets of the iShares Silver Trust Following the Suspension of the London Silver Fix
Business Wire - Thu Aug 14, 4:59PM CDT
iShares Delaware Trust Sponsor LLC, in its capacity as sponsor of iShares Silver Trust (SLV), is notifying shareholders regarding a change in the pricing source used in the evaluation of SLV's silver.

Will Silver Wheaton Deal With Vale for Salobo Gold Mine Pay Off?
at The Street - Wed Aug 06, 5:00AM CDT
Will Silver Wheaton���s Salobo mine, which was added to its portfolio last year, pay off now that the price of gold has dropped down the shaft?

Look for Shares of iShares Silver Trust to Potentially Rebound after Yesterday's 1.80% Sell Off
Comtex SmarTrend(R) - Tue Aug 05, 5:17PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $18.98 to a high of $19.23. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $19.34 on volume of 11.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

S&P 500 Continues to Fly Its Bear Flag
at The Street - Tue Aug 05, 3:38PM CDT
Why put money at risk when it is too dangerous to do so?

'Fast Money' Recap: This Is Not the Time to Panic
at The Street - Sat Aug 02, 4:00AM CDT
The trading panel looked at the U.S. market, German equities and 'best protection' trades.

Non-Farm Payroll May Cool Down the Gold and Silver Market
at The Street - Thu Jul 31, 2:48PM CDT
Friday's non-farm payroll report could keep dragging down gold and silver prices.

SmarTrend Watching for Potential Rebound in Shares of iShares Silver Trust After 2.49% Loss
Comtex SmarTrend(R) - Thu Jul 24, 3:56PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $19.50 to a high of $19.99. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $20.01 on volume of 11.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iShares Silver Trust Set to Possibly Rebound After Yesterday's Selloff of 2.49%
Comtex SmarTrend(R) - Thu Jul 24, 3:55PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $19.50 to a high of $19.99. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $20.01 on volume of 11.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Pan American Silver Is Just 1 Way to Invest in Silver
Lior Cohen, The Motley Fool - Motley Fool - Thu Jul 17, 1:17PM CDT
The silver market is slowly making a comeback after silver prices took a dive last year. The price of silver is now up by 11% this year. For investors thinking of entering the silver market, what are the main ways to invest in this precious metal?...

iShares Silver Trust (SLV) : Take profit @ $20.12
Trading Central - Tue Jul 15, 8:32AM CDT
The iShares Silver Trust is losing upward momentum as it is reversing down from its upper Bollinger band. We prefer to take profit right now at last price ($20.12) on long position opened in May 5th. Trading strategy: Close our long position at...

Watch for iShares Silver Trust to Potentially Rebound After Falling 2.28% Yesterday
Comtex SmarTrend(R) - Mon Jul 14, 4:23PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $20.01 to a high of $20.14. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $20.15 on volume of 8.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 43

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 38

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 35

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched into AppLovin Corporation's Alleged Fraud

Updated Category News Views 386

Investigation into AppLovin Corporation In recent news, a substantial class action lawsuit has emerged against AppLovin Corporation (NASDAQ: APP). This national law firm, known for advocating for investors, aims to hold the company accountable for alleged securities law violations. Understanding the Class Action Lawsuit This lawsuit pertains to any individuals or entities...

Continue Reading
Safe Harbor Financial Expands Support for Cannabis Operators

Updated Category News Views 33

Safe Harbor Financial Takes Bold Step in Cannabis Financing In a remarkable move, Safe Harbor Financial has successfully arranged a secured credit facility valued at $1.07 million. This milestone supports a cannabis operator, marking a significant step in bolstering financial services within the cannabis industry. With their expertise in facilitating innovative financial...

Continue Reading
Nidec Corporation Faces Securities Investigation: Key Insights

Updated Category News Views 224

Understanding Nidec Corporation's Current Challenges Nidec Corporation is undergoing scrutiny due to serious allegations in its business practices. This Japanese manufacturer, known for its electronic components, faces potential claims of issuing misleading information to its investors. Recent developments have raised questions about its transparency and accountability in...

Continue Reading
Understanding HCI Group's Short Interest Trends and Insights

Updated Category News Views 126

An Overview of HCI Group's Short Interest HCI Group's short interest has sparked interest among traders and investors alike, showing a recent increase of 7.38% from the previous report. This shift indicates that there are currently around 404 thousand shares sold short, comprising 4.95% of the company’s total tradable shares. Observing the trading volume, it has been...

Continue Reading
Fresenius Kabi Introduces New Epinephrine Injection for Patients

Updated Category News Views 151

Fresenius Kabi Launches Epinephrine Injection, USP Fresenius Kabi, a proud branch of the Fresenius organization, has taken a significant step in enhancing its pharmaceutical portfolio in the United States by making available Epinephrine Injection, USP. This launch positions Fresenius Kabi at the forefront as it becomes the first company to offer a generic 1mg/1mL vial of...

Continue Reading